Hace algún tiempo en A un clic anunciamos que se recetarían apps de salud y después hemos constatado que ya hay doctores que lo hacen . En el App Date Health que se celebró anteayer en Espacio Fundación Telefónica, José Fr
Via Juan Jesús Baño Egea
Your new post is loading...
Your new post is loading...
The global head of research at Sanofi put a policy in place to attach a digital health strategy concept to each molecule that goes through the pharmaceutical company’s pipeline. The fact that a digital strategy is reaching into the depths of the largest pharma companies is extremely encouraging for the continued evolution of clinical development, says Donald Jones, the chief digital officer at Scripps Translational Science Institute, which serves as the world’s first clinical trials center focused exclusively on digital medic
Via Alex Butler
Pharmaceutical firms must adopt and consistently execute practices that lead to digital excellence and give them a competitive edge. Which of these firms are accelerating away from the rest of the marketplace? We found that only two—Merck and Bristol-Myers Squibb—are doing reasonably well and achieving excellence and maturity in their digital capability. Firms taking a disciplined approach to digital transformation achieved higher maturity in digital capability than their less-disciplined peers.
Via Lionel Reichardt / le Pharmageek
For the last several years, I’ve been arguing that digital health provides an important opportunity to improve drug development, for several reasons.
First, by providing greater insight into the patient’s actual experience of disease, these technologies can reveal important differentiating features of new therapeutics, or point out aspects of illness that new medicines ought to attack.
Second, by offering a richer readout of phenotype, digital health measurements can reveal important disease subgroups, perhaps defined by a unique underlying mechanism that can be targeted. I’ve discussed this in detail recently, and won’t focus on this again here.
Digital health technologies can of course be helpful in a range of other ways, such as improving adherence, population analytics, clinical decision support, etc.
While some have hailed the adoption of digital health by pharma, that’s not my impression, at least on the R&D side. In my view, it remains very much on the “innovation initiative” side of things, rather than a clear business need (like pharmacology); drug development companies may be dipping their toes in and celebrating their bravery, but at best they are interested – certainly not what I’d call “pig committed.”
Via Alex Butler
The internet has added a whole new dimension to outside factors affecting a patient’s choice of care providers.
This is apparent by the fact that 82 percent of patients 50-plus now go to the internet for information on their care. CMS, Healthgrades and a host of other sites have made patient experience scores widely available. Social media has enabled people to expand their influence far beyond family and friends. Because Americans will tell twice as many people about a bad experience than a good one (White House Office of Consumer Affairs),it is more important than ever for physicians and hospitals to ensure patients not only receive excellent treatment, but their perception equals reality.
There are eight things you can do today to ensure your patient experience scores are high:
1. Realize you are in the ‘people’ business. Physicians and hospitals see their role as treating symptoms or illnesses, often losing sight of the person being treated. To ensure you provide the best care, consider what the person behind the treatment feels or needs.
2. Involve the patient. Today’s healthcare model requires patients to take a greater role in their treatment. Make sure you thoroughly discuss the pros and cons of the various treatment options so the patient will make the most informed decision without second thoughts.
3. Over communication. Regardless of how effective or efficient the treatment is, if patients do not know what to expect they will remain concerned throughout the process. By keeping them informed at every step, you are providing the reassurance they need to feel good about their experience.
4. Consider your audience. When communicating to patients, consider how your patients like to receive their information. Do you use email, telephone, or texts to remind patients of upcoming visits? Do you communicate with them between visits or provide educational materials?For some patients, there is nothing worse than to be given a pile of papers after an appointment. Most adults now prefer email or text messages, but you must ask to be sure.
5. Encourage questions. The best patients are actively engaged in their own care. Questions are the best way to gauge a patient’s level of understanding, and fill any gaps that may be present.
6. Look at all feedback as positive. According to “Understanding Customers” by Ruby Newell-Legner, only 4 percent of dissatisfied customers will voice their opinion while 91 percent will not come back. It is invaluable to uncover negative issues in your practice, so you can remedy the situation and keep more of your patients.
7. Coordinate services and visits. Whenever possible, combine visits or coordinate treatment to eliminate unnecessary visits. Patients and care givers are busy, and may be required to take off work for each appointment. Those with high deductibles or co-payments will look favorably on providers that help to lower their out-of-pocket expenses.
8. Work to get patients home sooner. The longer a patient stays in the hospital or a rehabilitation facility, the less satisfied they will be with their treatment. Programs with lower lengths of stay typically have higher scores.
AXA France est le 1er assureur à proposer, dans ses contrats santé, un service de Téléconsultation médicale. Il permet l’accès à des médecins généralistes pour une consultation médicale par téléphone. Ce service est accessible sur l’ensemble du territoire français.
Via Rémy TESTON
From fitness trackers to smart watches, the trend in gear is tracking and customization. Once a status symbol for fitness-focused folks and tech geeks, wearable tech has become ubiquitous, as has the underlying concept of using passively tracked information for personal benefit.
But in sporting the new connected accessories, there's a fine line between looking sophisticated and helplessly nerdy. Fashion is as important to men as it is women—and the majority surveyed by Men's Health said they'd think twice before donning a connected coat.
Via Alex Butler
One of the hottest topics for speculation in healthcare today is the unrealized potential for mobile health -- defined as technologies that use mobile devices, apps or telehealth to connect patients and physicians -- to transform the way healthcare is sought and delivered. Two-thirds of Americans own a smartphone, and companies are eager to tap this widespread technology for the benefit of patients, doctors and hospitals. But expert say it's not yet obvious how exactly mobile services might be leveraged in the bureucratic world of healthcare with its highly sensitive privacy issues.
Via Alex Butler
"E-Patient" is a term used to describe individuals who use the Internet and other tools to seek out, share and sometimes create information about health and wellness. Common words used to describe E-Patients: 1.e-patient, 2. internet patient, 3. health seeker, 4. cyberchondriac. As EHR implementation and adoption becomes more commonplace across the health care environment, providers are beginning to focus more on maximizing the value from their investment. Stakeholder engagement is a critical success factor for the effective use of EHRs and other health IT and patients are one of the last, and most important, groups to get involved in this process. While EHRs continue to evolve and technologies like patient portals become more common, providers have the opportunity to drive improvements in quality by encouraging patients to become an active participant in their own care.
Digital medicine is poised to transform biomedical research, clinical practice and the commercial sector. Here we introduce a monthly column from R&D/venture creation firm PureTech tracking digital medicine's emergence.
Technology has already transformed the social fabric of life in the twenty-first century. It is now poised to profoundly influence disease management and healthcare. Beyond the hype of the 'mobile health' and 'wearable technology' movement, the ability to monitor our bodies and continuously gather data about human biology suggests new possibilities for both biomedical research and clinical practice. Just as the Human Genome Project ushered in the age of high-throughput genotyping, the ability to automate, continuously record, analyze and share standardized physiological and biological data augurs the beginning of a new era—that of high-throughput human phenotyping.
These advances are prompting new approaches to research and medicine, but they are also raising questions and posing challenges for existing healthcare delivery systems. How will these technologies alter biomedical research approaches, what types of experimental questions will researchers now be able to ask and what types of training will be needed? Will the ability to digitize individual characteristics and communicate by mobile technology empower patients and enable the modification of disease-promoting behaviors; at the same time, will it threaten patient privacy? Will doctors be prescribing US Food and Drug Administration (FDA)-cleared apps on a regular basis, not just to monitor and manage chronic disease but also to preempt acute disease episodes? Will the shift in the balance between disease treatment and early intervention have a broad economic impact on the healthcare system? How will the emergence of these new technologies reshape the healthcare industry and its underlying business models? What will be the defining characteristics of 'winning' products and companies?
These are just some of the questions we plan to ask over the coming months. In the meantime, we introduce here some of the key themes shaping R&D in the digital medicine field and focus on what they might mean for the biopharmaceutical and diagnostic/device industries.
Via Dr. Stefan Gruenwald
Good doctor blogging is a lot like good doctoring: Listen to patients and try to meet their needs. Extra points for being funny, warm, thoughtful and, most of all, engaging. Try some or all of these patient-friendly content types on your medical practice blog:
1. Answer frequently asked questions
Howard J. Luks, an orthopedic surgeon in Westchester and Dutchess Counties, New York, bases his blog on questions his patients ask in office, writing posts such as “Why Does the Front of My Knee Hurt?” and “You Have Torn Your Meniscus: What’s Next?” He explains how he comes up with blog post ideas in “Great Medical Blog Content: Think Like a Patient”.
2. Give health tips (with numbers)
For some reason, titles with numbers do well on the internet, probably because they promise the reader quick, concise information delivery. Take a look at “Atrial Flutter — 15 facts you may want to know” from the blog of cardiologist John Mandrola in Louisville, Kentucky.
3. Shoot video
Las Vegas internist Zubin Damania’s blog is a collection of parody music videos starring his alter ego ZDoggMD—they’re a little bit educational and a lot funny. That’s him in the image above, explaining Obamacare. Watch Damania do Taylor Swift as a doctor-shopping pill addict in “Blank Script” and Garth Brooks in “Friends with Low Platelets”. If you don’t have his singing and acting talent, a simple explanatory video like “What is Plantar Fasciitis?” by Philadelphia sports podiatrist Lee S. Cohen is fine. Just don’t expect to get ZDogg’s hundreds of thousands of video views on YouTube.
4. Chronicle the silly side of daily life as a doc
The author of the Dr. Grumpy in the House blog is anonymous, and a good thing too because the blog is all about the inane things his or her patients do or say, mostly told in verbatim dialogue, like this phone call:
Mrs. Call: “My husband is having a seizure. He sees Dr. Nerve for epilepsy.”
Dr. Grumpy: “Okay, do you have a medication to give him for seizures?”
Mrs. Call: “It’s in the bathroom. Can’t I just hold the phone next to him and you tell him to stop?”
5. Explore the doctor-patient relationship
Dr. Val Jones runs health education company Better Health and her blog posts at GetBetterHealth.com like “Why Do Patients Lie to Doctors?” go to the heart of the doctor-patient relationship and are equally readable by those on both sides of the stethoscope. She suggests some blog post topics for doctors in this list.
6. Filter the news
Patients need a guide to point out what’s important in the mountain of health news and information on the internet. That could be you. Dr. Sanjay Gupta’s The Chart blog on CNN.com is a good example of creating a news feed by highlighting a few of the many medical studies that get published.
7. Pick a niche, be an authority and do it with a distinctive voice
Greenville, South Carolina, pediatrician Chad Hayes blogs on “demystifying parenting and pediatrics” in a straight-talking style, like the post “Just Call It ‘Colic’: The Diagnosis That Isn’t”, a refreshing admission that doctors don’t really know much about a common condition. Colin E. Champ, a Pittsburgh radiation oncologist, blogs atCavemanDoctor.com, advocating for the “caveman diet” and critiquing conventional wisdom in medicine, diet and exercise.
And watch this blog for more tips and inspiration…
Pioneering doctor blogger Kevin Pho, a primary care doc in Nashua, New Hampshire, gives hands-on advice on running a blog and links to the latest posts from hundreds of other doctor blogs at KevinMD.com.
Gamers everywhere rejoice! It turns out that gaming prowess is an indication of a better connected brain. This latest conclusion was drawn from research which looked at the cognitive function of Action Video Gamers (AVGs) of different levels of proficiency. For the ‘noobs’ out there, action video games subject the gamer to physical challenges, including hand–eye coordination and reaction-time games. This could be racing or fighting for example.
L’idée peut paraitre surprenante, mais Apple devrait lancer une application destinée à stocker son patrimoine génétique sur le Cloud, afin de pouvoir l’analyser depuis son smartphone. L’idée serait de mieux comprendre les maladies et d’améliorer la médecine, une multitude d’applications devraient à terme pouvoir révolutionner le domaine médical.
Gravit est un éditeur de photos en ligne proposé gratuitement. C’est un projet qui propose l’un des outils les plus complets sur Internet pour le graphisme. Gravit met en avant de nombreuses fonctions et outils d’édition d’images. Vous pouvez appliquer des filtres et effectuer différents types de réglages. En fait, ces modifications peuvent être comparées à celle de Photoshop, rien que ça ! Voici Gravit, le Photoshop gratuit et en ligne…
Via Frédéric DEBAILLEUL
Bigger isn't necessarily better when it comes to social media. But bigger is certainly better than drugmakers were doing a couple of years ago. Some companies are actually getting it right now, Ogilvy Healthworld says.
A small group of drugmakers are "connecting the dots," according to Ogilvy's latest audit of pharma's social media efforts. They're getting patients, doctors and the media interested, delivering relevant info, inspiring actual conversations.
A very small group, actually. Just 5 companies out of 14 that Ogilvy investigated. We'll get to those later. First, let's consider the fact that pharma's social media presence has grown--a lot. Drugmakers have 1.3 million Facebook followers, Ogilvy says. The average number of pharma tweets per week has gone up by 530% since 2013. The number of Twitter followers has tripled, to 790,000. Four companies even have Vine accounts.
"We know that some pharma companies have been cautious in their approach to social media, but our report clearly demonstrates a dramatic and successful increase in activity," Rebecca Canvin, social media manager at Ogilvy Healthworld, said in a release.
Some have been more successful than others, of course. To go from size to success, Ogilvy looked at more stats--how many followers, how frequent the updates, how many social accounts, how often posts or tweets were shared. The auditors also gauged interest--how much did followers care about a company's social chatter?
Which company came out on top won't be a surprise to those who keep an eye on such things: Boehringer Ingelheim, already a leading presence in 2013, took that lead much further. The German drugmaker's score almost doubled that of its closest rival, Bayer. And Bayer, in turn, bested third-place Novartis ($NVS) by an easy margin.
The remaining two companies "connecting the dots" were Merck ($MRK) and Johnson & Johnson ($JNJ), both of which made big leaps from 2013. In fact, all of the top 5 multiplied their social presences significantly.
Four other drugmakers have made some strides and some connections since Ogilvy's last audit. The rest are still doing the social thing at a beginner level--broadcasting content without engaging much at all, the audit showed.
It's a good thing for them that Ogilvy analyzed their successful peers to come up with some tips for improvement. "[I]t's time to be brave, get personal, educate and integrate social media into their wider marketing strategy," Canvin said.
But why? As the current experts at Boehringer told Ogilvy, the conversation is already out there. "People are talking about you, whether you're active or not," said Patricia Alves, Boehringer's social media and community manager. "Social media gives you the opportunity to engage in that conversation, to give your position and your statement, and maybe then hopefully change the opinion of one person or two."
- check out the Ogilvy Healthworld statement
Today’s digital social age presents an incredible opportunity for the pharmaceutical and healthcare industries. For years, the struggle to understand evolving patient needs in order to strategically align and address them has been at the forefront of the value proposition for healthcare. However, gaining deep, trustworthy insight into the journeys patients traverse has been a daunting challenge.
Today the dynamics have completely shifted in the “open social age.” With millions of patients broadcasting their experiences, reactions, behaviors, decisions and attitudes on their conditions, treatments and providers, there is an incredible wealth of “big data” available. With this, however, the daunting challenge has shifted from a lack of detailed insight to a tsunami of real-time information.
As society approaches a complete digital state, technological advances have transformed the way people work, learn, communicate and share. And consumers freely share their opinions and experiences on social networks, blogs, micro-blogs, message boards, forums, mainstream news sites and a variety of other online platforms. They do this on practically every topic spanning their lives, including their health.
On-Line All the Time
According to a study conducted by Morgan Stanley, 91 percent of mobile users keep their device within three feet of them 24-hours per day. These mobile devices are now widely a standardization of life; people watch TV with them, shop with them and yes, make their medical decisions with them in-hand.
This ‘always on’ state that mobile online accessibility facilitates is enhancing the way healthcare decisions and activities are undertaken, from understanding symptoms and diagnoses to learning about treatment options and side effects. This, along with the all-time accessibility of mobile devices has made the wealth of information ubiquitous in the ‘offline’ world.
An Ever-Changing Journey
The empowerment patients have with this information access presents a challenge for pharmaceutical and health brand managers to keep pace with the ever-changing journey the patient (and caregiver) takes. The massive flow of information from a myriad of sources, including those across the open social universe, creates a wide array of paths patients can take towards their treatments. This wealth of information also increases the velocity of health decisions, including compliance, often compressing the time between demand moments and decision points, making it even more challenging for the treatment provider to identify and influence the decision with messaging or education.
The key to driving success with care is for these treatment providers to deeply understand patients, caregivers and healthcare providers by continually mapping each party’s journey as it shifts with their experiences and attitudes. Leveraging this insight to drive messaging, education and innovation to align with the patients’ needs (met and unmet) is critical in enhancing their overall care.
Mapping the Journey
The basis of understanding the patient journey today is mapping it with advanced social intelligence. To adequately accomplish this, it must be derived from the ‘big data’ mining of millions of daily patient social conversations. This is simple in concept, but challenging in technical execution. This is why so many leading brands are turning to advanced, streaming ‘big data’ solutions to deliver deep insights on a rapid basis of patients as well as their caregivers and healthcare providers.
In the following example the patient journey is mapped for a specific treatment option for low testosterone. The journey spans stages from symptoms and diagnosis through treatment and management of the condition. This map also reviews the patient journey based on a multidimensional view of factors ranging from lifestyle impact and cost to efficacy and compliance.
This provides a valuable view of the demand moments, decision points and influencing factors for the patient. This allows the brand team to understand when and how to engage and influence the patient’s path in order to enhance aspects like compliance and ultimately efficacy of the treatment.
The level of detail that can be constructed within the online patient journey gets as granular as patient feelings, lexicon, attitudes and behaviors at each of the identified journey stages. This delivers powerful insight into the patient’s state of mind to drive strategic aspects of the treatment from education to messaging and in turn can influence compliance and overall efficacy of the treatment.
An Intelligence Impact
Today, with advanced social intelligence, accurately mapping patient journeys has never been easier, more accurate or powerful. As compliance and efficacy continue to be a focus to improve patient care, having the ability to view, understand and influence the patient journey becomes increasingly critical for health and pharmaceutical companies. Extracting unprecedented insights within millions of daily social conversations from patients, caregivers and healthcare professionals now facilitates this, allowing pharmaceutical providers to align their treatments, education, messaging and innovation with the needs of the patients like never before.
Hear more from ListenLogic as well as new ideas about the Patient’s Journey and Social Media from Industry Leaders
As new technologies within the industry progress, we must also advance our message and utilization of the social technologies available to create a complete user-centric experience for the patient. See how you can learn from leaders in this movement at 6th Digital Pharma West, taking place in San Francisco, CA in the United States on June 1-3, 2015.